Perceptive Advisors LLC, Director, 10% Owner at Lyra Therapeutics, Inc. (LYRA), bought 11,848,340 shares at $4.22 ($50.0M) on 2022-04-12, disclosed to the SEC on 2022-04-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.22 | 5,924,170 | $25.0M | 50.0% |
| 2 | $4.22 | 5,924,170 | $25.0M | 50.0% |
| Total | $4.22 avg | 11,848,340 | $50.0M | 100% |
| Filing → |
| ACRV | SELL | 2025-05-01 | $2.0M | — | Filing → |
| ACRV | SELL | 2025-04-29 | $5.1M | — | Filing → |
| VRCA | BUY | 2023-12-26 | $3.6M | — | Filing → |